CTTC owns equity in a diverse group of companies that span a range of technologies including computerized surgical navigation, natural products for insect control, clinical information management systems, clinical diagnostics, drug discovery, radiation therapy, and healthcare services - all of which are powered by Vanderbilt technologies. The Center’s active portfolio currently includes, (non-exhaustive list):
Innovative solutions to address unmet needs in diabetes care
American Sentinel University
Biopharmaceutical Drug Development Company with Innovative Peptide-based Solutions for Inflammation and Metabolic Syndrome
Healthcare data consultant
Appello Pharmaceuticals, Inc.
Focused on advancing novel positive allosteric modulators of mGlu4 for the treatment of Parkinson’s disease.
Medical devices infused with bionanotechnology
Cumberland Emerging Technologies
Life sciences business incubation
Colorectal cancer screening tool
Enables the application of genomics in oncology to improve patient care
Discovery and development of human monoclonal antibodies for the prevention, treatment, and cure of infectious diseases.
Informatics Corporation of America
Clinical IT systems
International FemtoScience, Inc.
Research & development for advanced technology
RNA Autoimmune Diagnostics & Analytics
CQI software and services
Crew training for healthcare
Assay services and products
Renal disease diagnostics and therapeutics
nPhaseMachine to machine wireless communications and services for healthcare, manufacturing, utilities, distribution, and consumer product industries.
Path Ex, Inc.
PATH EX is an extracorporeal blood cleansing device designed to selectively remove bacteria, including multi-drug resistant strains, and endotoxin from circulating blood.
Drug delivery system
Personalize cancer therapy
Natural insect control products
Hardware-independent software engineering company specializing in machine learning
Transforming minimally invasive surgery by providing surgeons with dexterous, accurate, and cost-effective robotic tools through endoscopes.
Developing a low-cost, non-invasive device that measures fluid status
Drug Discovery Tools